Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intepirdine in Alzheimer's disease
NCT02586909Phase 3Terminated
- Sponsor
- Sio Gene Therapies
- Start
- Apr 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of intepirdine in Alzheimer's disease (AD), sponsored by Sio Gene Therapies. Started Apr 2016; status: terminated.
02
Drugs
intepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02586909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586909.